Sex differences in blood genotoxic and cytotoxic effects as a consequence of vanadium inhalation: Micronucleus assay evaluation

Journal of Applied Toxicology

Volumn 34, Issue 3, 2014, Pages 258-264

  Rojas Lemus, Marcela ^a   Altamirano Lozano, Mario ^b   Fortoul, Teresa I ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cytotoxicity; Genotoxicity; Micronucleus; Reticulocytes; Sex differences; Vanadium pentoxide

Indexed keywords

FLUOROCHROME; VANADIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TOXICITY; BONE MARROW; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; FEMALE; GENOTOXICITY; INHALATION; LEUKOCYTE; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE; RETICULOCYTE COUNT; SEX DIFFERENCE;

CYTOTOXICITY; GENOTOXICITY; MICRONUCLEUS; RETICULOCYTES; SEX DIFFERENCES; VANADIUM PENTOXIDE;

ANIMALS; CELL SURVIVAL; ENVIRONMENTAL POLLUTANTS; FEMALE; INHALATION EXPOSURE; LEUKOCYTES; MALE; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; RETICULOCYTES; SEX CHARACTERISTICS; VANADIUM COMPOUNDS;

EID: 84893006080     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2873     Document Type: Article

References (62)

1. Agency for Toxic Substances and Disease Registry (ATSDR). 2012. Toxicological Profile for Vanadium. Department of Health and Human Services, Public Health Service: Atlanta, GA.
2. Aguirre MV, Juaristi JA, Alvarez MA, Brandan NC. 2005. Characteristis of in vivo murine erythropoietic response to sodium orthovanadate. Chem. Biol. Interact. 156: 55-68.
3. Altamirano-Lozano M, Alvarez-Barrera L, Basurto-Alcántara, Valverde M, Rojas E. 1996. Reprotoxic and genotoxic studies of vanadium pentoxide in male mice. Teratog. Carcinog. Mutagen. 16: 7-17.
4. Altamirano-Lozano M, Valverde M, Alvarez BL, Molina B, Rojas E. 1999. Genotoxic studies of vanadium pentoxide (V2O5) in male mice. II. Effects in several mouse tissues. Teratog. Carcinog. Mutagen. 19: 243-255.
5. Amantea D, Russo R, Bagetta G, Corasaniti MT. 2005. From clinical evidence to molecular mechanism underlying neuroprotection afforded by estrogens. Pharmacol. Res. 52: 119-132.
6. Ávila-Costa MR, Colín BL, Zepeda RA, Antuna BS, Saldivar L, Espejel MG, Mussali GP, Ávila CMC, Reyes OA, Anaya MV, Fortoul TI. 2005. Ependymal epithelium disruption after vanadium pentoxide inhalation. A mice experimental model. Neurosci. Lett. 381: 21-25.
7. Ávila-Costa MR, Montiel FE, Colín BL, Ordoñez JL, Gutiérrez AL, Niño CHG, Mussali GP, Fortoul TI. 2004. Nigrostriatal modifications after vanadium inhalation: an inmunocytichemical and cytological approach. Neurochem. Res. 29: 1365-1369.
8. Badeau M, Adlercreutz H, Kaihovaara P, Tikkanen MJ. 2005. Estrogen A-ring structure and antioxidative effects on lipoproteins. J. Steroid Biochem. Mol. Biol. 96: 271-278.
9. Behl C. Oestrogen as a neuroprotctive hormone. 2002. Nat. Rev. Neurosci. 3: 433-442.
10. Boobis AR, Cohen SM, Doerrer NG, Galloway SM, Haley PJ, Hard GC, Hess FG, Macdonald JS, Thibault S, Wolf DC, Wrigth J. 2009. Data-based assessment of alternative strategies for identification of potential human cancer hazards. Toxicol. Pathol. 37: 714-732.
11. Borras C, Satre J, García-Sala D, Lloret A, Pallardó FV, Viña J. 2003. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic. Biol. Med. 34: 546-552.
12. Chakraborty T, Chatterjee A, Rana A, Dhachinamoorthi D, Kumar PA, Chatterjee M. 2007. Carcinogen-induced early molecular events and its implication in the initiation of chemical hepatocarcinogenesis in rats: chemopreventive role of vanadium of this process. Biochim. Biophys. Acta 1772: 48-59.
13. Choi JH, Kim JS, Kim YC, Kim YS, Chung NH, Cho MH. 2004. Comparative study of PM2.5- and PM10-induced oxidative stress in rat lung epithelial cells. J. Vet. Sci. 5: 11-18.
14. Ciranni R, Antonetti M, Migliore L. 1995. Vanadium salts induce cytogenetic effects in vivo treated mice. Mutat. Res. 343: 53-60.
15. Cohen MD, Klein CB, Costa M. 1992. Forward mutations and DNA-protein crosslinks induced by ammonium metavanadate in cultured mammalian cells. Mutat. Res. 269: 141-148.
16. Cooper R. 2007. Vanadium pentoxide inhalation. Indian J. Occup. Environ. Med. 11: 97-103.
17. Dill JA, Lee KM, Mellinger KH, Bates DJ, Burka LT, Roycroft JH. 2004. Lung deposition and clearance of inhaled vanadium pentoxide in chronically exposed F344 rats and B6C3F1 mice. Toxicol. Sci. 77: 6-18.
18. Duffus JH. Carcinogenicity classification of vanadium pentoxide and inorganic vanadium compounds, the NTP study of carcinogenicity of inhaled vanadium pentoxide, and vanadium chemistry. 2007. Regul. Toxicol. Pharmacol. 47: 110-114.
19. Evangelou AM. Vanadium in cancer treatment. 2002. Crit. Rev. Oncol. Hematol. 42: 249-265.
20. Fenech M. 2000. The in vitro micronucleus technique. Mutat. Res. 455: 81-95.
21. Fortoul TI, Moncada-Hernández S, Saldivar-Osorio, Espejel-Maya G, Mussali-Galante P, Ávila-Casado MC, Colín-Barenque L, Hernández-Serrato MI, Ávila-Costa MR. 2005. Sex differences in bronchiolar epithelium response after the inhalation of lead acetate (Pb). Toxicology 207: 323-330.
22. Fortoul TI, Piñón-Zarate G, Diaz-Bech ME, González-Villalva A, Mussali-Galante P, Rodriguez-Lara V, Colin-Barenque L, Martinez-Pedraza M, Montaño LF. 2008. Spleen and Bone Marrow Megakaryocytes as targets for inhaled vanadium. Histol. Histopathol. 23: 1321-1326.
23. Fortoul TI, Rodriguez-Lara V, Gonzalez-Villalva A, Rojas-Lemus M, Cano-Gutierrez G, Ustarroz-Cano M, Colin-Barenque L, Montaño LF, García-Pelez I, Bizarro-Nevares P, Lopez-Valdez N, Falcon-Rodriguez CI, Jimenez-Martínez RS, Ruiz-Guerrero ML, López-Zepeda LS, Morales-Rivero A, Muñiz-Rivera-Cambas A. 2011. Vanadium inhalation in a mouse model for the understanding of air-suspended particle systemic repercussion. J. Biomed. Biotechnol. 2011: 951043.
24. Fortoul TI, Valverde M, López MC, Avila-Costa MR, Avila-Casado MC, Mussali-Galante P, Gonzalez-Villalva A, Rojas E, Ostrosky-Shejet P. 2004. Genotoxic differences by sex in nasal epithelium and blood leukocytes in subjects residing in a highly polluted area. Environ. Res. 94: 243-248.
25. Fortoul TI, Quan-Torres A, Sanchez I, Lopez I, Bizarro P, Mendoza ML, Osorio LS, Espejel-Maya G, Avila-Casado MC, Avila-Costa MR, Colin-Barenque L, Villanueva DN, Olaiz-Fernandez G. 2002. Vanadium in ambient air: Concentrations in lung tissue from autopsies of Mexico City residents in the 1960s and 1990s. Arch. Environ. Health 57: 446-449.
26. Ghio AJ, Silbajoris R, Carson JL, Samet JM. 2002. Biologic effects of oil fly ash. Environ. Health Perspect. 110: 89-94.
27. González-Villalva A, Rodríguez LV, Montaño LF, Lima-Melo A, Ramírez G, Fortoul TI. 2009. Blood changes generated after vanadium inhalation. Curr. Tops Toxicol. 6: 31-38.
28. Goodnough LT, Skikne B, Brugnara C. 2000. Erythropoietin, iron and erythropoiesis. Blood 96: 823-833.
29. Halliwell B, Gutteridge JM. 1984. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 21: 1-14.
30. Hayashi M, Morita T, Kodama Y, Sofuni T, Ishidate M. 1990. The Micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res. 245: 245-249.
31. Hernandez H, Rodríguez R. 2011. Geochemical evidence for the origin of vanadium in an urban environment. Environ. Monit. Asses. 184: 5327-5342.
32. Hogan GR. 1990. Peripheral erythrocyte levels, hemolysis and three vanadium compounds. Experientia 15: 46: 444-446.
33. Ivancsits S, Pilger A, Diem E, Schaffer A, Rüdiger W. 2002. Vanadate induces DNA strand breaks in cultured human fibroblasts at doses relevant to occupational exposure. Mutat. Res. 519: 25-35.
34. Iversen PO. 1997. Blood flow to the haemapoietic bone marrow. Review article. Acta Physiol. Scand. 159: 269-276.
35. Kleinsasser NH, Dirschedl P, Staudenmaier R, Harréus UA, Wallner BC. 2003. Genotoxic effects of vanadium pentoxide on human peripheral lymphocytes and mucosal cells of the upper aerodigestive tract. Int. J. Environ. Health Res. 13: 373-379.
36. Krishna G, Hayashi M. 2000. In vivo rodent micronucleus assay: protocol, conduct and data interpretation. Mutat. Res. 455: 155-166.
37. Leonard A, Gerber GB. 1994. Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutat. Res. 317: 81-88.
38. Mayani H, Flores-Figueroa E, Pelayo R, Montesinos JJ, Flores-Guzmán P, Chávez-González A. 2007. Hematopoyesis. Cancerología 2: 95-107.
39. Migliore L, Bocciardi R, Macrì C, Lo Jacono F. 1993. Cytogenetic damage induced in human lymphocytes by four vanadium compounds and micronucleus analysis by fluorescence in situ hybridization with a centromeric probe. Mutat. Res. 319: 205-213.
40. Mussali-Galante P, Rodriguez LV, Hernandez TB, Avila CMR, Colin BL, Bizarro NP, Martinez LG, Rojas LM, Piñon ZG, Saldivar OL, Diaz BP, Fortoul TI. 2005. Inhaled vanadium pentoxide decrease gamma-tubulin of mouse testes at different exposure time. Toxicol. Ind. Health 21: 215-222.
41. NTP. 2002. NTP Technical Report on the Toxicology and Carcinogenicity Studies of Vanadium Pentoxide (CAS NO. 1314-62-1) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program, Research Triangle Park NC. NTP TR 507, NIH Publication No. 03-4441, pp. 352, dated December 2002.
42. Ramírez P, Eastmond DA, Laclette JP, Ostrosky-Wegman P. 1997. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat. Res. 386: 291-298.
43. Rodríguez-Mercado JJ, Alvarez-Barrera L, Altamirano-Lozano M. 2010. Chromosomal damage induced by vanadium oxides in human peripheral lymphocytes. Drug Chem. Toxicol. 33: 97-102.
44. Rodríguez-Mercado JJ, Mateos-Nava RA, Altamirano-Lozano MA. 2011. DNA damage induction in human cells exposed to vanadium oxides in vitro. Toxicol. In Vitro 25: 1996-2002.
45. Rodríguez-Mercado JJ, Roldán-Reyes E, Altamirano-Lozano M. 2003. Genotoxic effects of vanadium (IV) in human peripheral blood cells. Toxicol. Lett. 144: 359-369.
46. Rojas E, Valverde M, Herrera LA, Altamirano-Lozano M, Ostrosky-Wegman P. 1996. Genotoxicity of vanadium pentoxide evaluate by the single cell gel electrophoresis assay in human lymphocytes. Mutat. Res. 359: 77-84.
47. Roldán RE, Altamirano LM. 1990. Chromosomal aberrations, sister-chromatid exchanges, cell-cycle kinetics and satellite associations in human lymphocyte cultures exposed to vanadium pentoxide. Mutat. Res. 245: 61-65.
48. Samanta S, Swamy V, Suresh D, Rajkumar M, Rana B, Rana A, Chatterjee M. 2008. Protective effects of vanadium against DMH-induced genotoxicity and carcinogenesis in rat colon; removal of O(6)-methylguanine DNA adducts, p53 expression, inducible nitric oxide synthase down regulation and apoptotic induction. Mutat. Res. 650: 123-131.
49. Slupphaug G, Kavli B, Krokan HE. 2003. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat. Res. 531: 231-251.
50. Starr TB, Macgregor JA, Ehman KD, Kikiforov AI. Vanadium pentoxide: use of relevant historical control data shows no evidence for a carcinogenic response in F344/N rats. 2012. Regul. Toxicol. Pharmacol. 64: 155-160.
51. Strauss GHS. 1991. Non-random cell killing in cryopreservation: Implications for performance of the battery of leukocytes tests (BLT). I. Toxic and immunotoxic effects. Mutat. Res. 252: 1-15.
52. Tamir S, Izrael S, Vaya J. 2002. The effect of oxidative stress on ER-a and ER-b expression. J. Steroid Biochem. Mol. Biol. 81: 327-332.
53. Ustarroz-Cano M, Garcia-Pelaez I, Piñon-Zarate G, Herrera-Enriquez M, Soldevila G, Fortoul TI. 2012. CD11c decrease in mouse thymic dendritic cells after vanadium inhalation. J. Immunotoxicol.. Early Online: 1-7.
54. Vahter M, Akeson A, Lidén C, Ceccatelli S, Berglund M. 2007. Gender differences in the disposition and toxicity of metals. Environ. Res. 104: 85-95.
55. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interac. 160: 1-40.
56. Vallejo M, Jáuregui-Renaud K, Hermosillo AG, Márquez MF, Cárdenas M. 2003. Efectos de la contaminación atmosférica en la salud y su importancia en la ciudad de México. Gac. Med. Mex. 139: 57-63.
57. Villani P, Cordelli E, Leopardi P, Siniscalchi E, Veschetti E, Fresegna AM, Crebelli R. 2007. Evaluation of genotoxicity of oral exposure to tetravalent vanadium in vivo. Toxicol. Lett. 170: 11-18.
58. Yip M, Madl P. 2002. Air Pollution in Mexico City: Project-Study paper. University of Salzburg, Austria. Academic Information Systems, Lund University Library.
59. Zalacain M, Sierrasesúmaga L, Patiño A. El ensayo de micronúcleos como medida de inestabilidad genética. 2005. Anales Sis San Navarra. 28: 227-236.
60. Zaporowska H, Wasilewski W. 1992. Haematological results of vanadium intoxication in Wistar rats. Comp. Biochem. Physiol. C 101: 57-61.
61. Zhong BZ, Gu ZW, Wallace WE, Whong WZ, Ong T. 1994. Genotoxicity of vanadium pentoxide in Chinese hamster V79 cells. Mutat. Res. 321: 35-42.
62. World Health Organization (WHO). 2001. International Program on Chemical Safety. Concise international chemical assessment document. Vanadium Pentoxide and other inorganic vanadium compounds. WHO: Copenhagen.